Aclaris Therapeutics
ACRS
ACRS
137 hedge funds and large institutions have $480M invested in Aclaris Therapeutics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 61 increasing their positions, 34 reducing their positions, and 16 closing their positions.
Holders
137
Holders Change
+4
Holders Change %
+3.01%
% of All Funds
2.18%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
20
Increased
61
Reduced
34
Closed
16
Calls
$22.1M
Puts
$15.8M
Net Calls
+$6.35M
Net Calls Change
+$9.8M
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$48.4M |
| 2 |
2
Blackstone Inc
New York
|
$8.64M |
| 3 |
3
Millennium Management
New York
|
$13.5M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$23M |
| 5 |
ACM
5
Altium Capital Management
New York
|
$2.76M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
US Bancorp
Minneapolis,
Minnesota
| – | -$7.82K | -754 | Closed |
|
|
PA
152
Parallel Advisors
San Francisco,
California
| – | -$5.19K | -500 | Closed |
|